Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Childhood Leukemia 2016 NCI 1K22CA197074-01 Exosomic microRNAs and drug resistance in AML tumor microenvironment CHALLAGUNDLA, KISHORE UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $154,958
Childhood Leukemia 2016 NCI 4R01CA072669-19 Cytotoxic-T-Lymphocyte (CTL) Therapy of AML BLAZAR, BRUCE UNIVERSITY OF MINNESOTA MN $294,076
Childhood Leukemia 2016 NCI 5R01CA132640-15 Role of heat shock factors (Hsfs) in tumorigenesis MIVECHI, NAHID GEORGIA REGENTS UNIVERSITY GA $270,000
Childhood Leukemia 2016 NCI 5R01CA190964-02 Role of IKAROS in the Biology and Therapy of High-Risk Precursor B-Cell Leukemia VAN ETTEN, RICHARD UNIVERSITY OF CALIFORNIA-IRVINE CA $544,106
Childhood Leukemia 2016 NHLBI 5K08HL118367-03 ELUCIDATING THE ROLE OF KRUPPEL LIKE FACTOR 7 IN T CELL DEVELOPMENT SCHUETTPELZ, LAURA WASHINGTON UNIVERSITY MO $26,438
Childhood Leukemia 2016 NCI 5R01CA090668-13 FLT3 Tyrosine Kinase Inhibitors as Therapy for Leukemia SMALL, DONALD JOHNS HOPKINS UNIVERSITY MD $291,600
Childhood Leukemia 2016 NCI 4R01CA158006-05 Ikaros-based epigenetic regulation of T cell leukemogenesis GEORGOPOULOS, KATIA MASSACHUSETTS GENERAL HOSPITAL MA $342,218
Childhood Leukemia 2016 NCI 5R01CA182528-04 Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $336,114
Childhood Leukemia 2016 NICHD 4R01HD062484-06 Pharmacogenetic Determinants of Vincristine Toxicity and Response RENBARGER, JAMIE INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $614,577
Childhood Leukemia 2016 NCI 4R01CA167708-04 Targeting AML with PI3K/AKT inhibitors and BH3-mimetics GRANT, STEVEN VIRGINIA COMMONWEALTH UNIVERSITY VA $284,794
Childhood Leukemia 2016 NCI 5R01CA191077-02 Assay Development for NSD1 Methyltransferase Inhibitor Discovery NAPPER, ANDREW ALFRED I. DU PONT HOSP FOR CHILDREN DE $312,244
Childhood Leukemia 2016 NCI 5R01CA185301-02 Enhancing NK Cell Activity by Dietary Diphyllin Lignans for Cancer Prevention CALIGIURI, MICHAEL OHIO STATE UNIVERSITY OH $352,275
Childhood Leukemia 2016 NCI 5K08CA181340-03 Targeting Chromatin Modifications in Leukemia with Trisomy 21 LANE, ANDREW DANA-FARBER CANCER INST MA $155,991
Childhood Leukemia 2016 NCI 5F30CA183507-03 Cytotoxicity of MLN4924 in Acute Myeloid Leukemia KNORR, KATHERINE MAYO CLINIC ROCHESTER MN $42,276
Childhood Leukemia 2016 NCI 4R01CA173636-04 Role of TET2 mutations in malignant transformation and acute myeloid leukemia LEVINE, ROSS SLOAN-KETTERING INST CAN RESEARCH NY $639,626
Childhood Leukemia 2016 NHLBI 5R01HL117976-03 Epithelial mechanisms of inducible resistance to AML-associated pneumonia EVANS, SCOTT UNIVERSITY OF TX MD ANDERSON CAN CTR TX $400,000
Childhood Leukemia 2016 NCI 5R01CA137060-08 PRE-B CELL RECEPTOR SIGNALING IN ACUTE LYMPHOBLASTIC LEUKEMIA MUSCHEN, MARKUS UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $356,625
Childhood Leukemia 2016 NCI 4R37CA072614-20 Translational Investigation of KRas & NF1 in Myeloid Leukemia SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $304,773
Childhood Leukemia 2016 NCI 4R01CA172398-04 The role of ETV6 in T-cell acute lymphoblastic leukemia FERRANDO, ADOLFO COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Childhood Leukemia 2016 NCI 4R01CA160433-05 The Role of Telomere Shortening in MDS-AML Pathogenesis (resubmission) ARMANIOS, MARY JOHNS HOPKINS UNIVERSITY MD $336,150
Childhood Leukemia 2016 NCI 5F30CA183269-03 Exosomal MicroRNA as a Driver of Immune Evasion in AML HORNICK, NOAH OREGON HEALTH & SCIENCE UNIVERSITY OR $42,732
Childhood Leukemia 2016 NCI 2P30CA016520-40 8007 Hematologic Malignancies Research Program STADTMAUER, EDWARD UNIVERSITY OF PENNSYLVANIA PA $72,887
Childhood Leukemia 2016 NCI 5R33CA191143-02 Single cell growth assay for residual cells in acute lymphoblastic leukemia MANALIS, SCOTT MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $366,536
Childhood Leukemia 2016 NCI 5F31CA183529-03 Targeting aerobic glycolysis in T-ALL KISHTON, RIGEL DUKE UNIVERSITY NC $17,159
Childhood Leukemia 2016 NCI 4R01CA172268-04 The role of inhibitory receptors in leukemia development ZHANG, CHENGCHENG UT SOUTHWESTERN MEDICAL CENTER TX $329,925
Childhood Leukemia 2016 NCI 4R01CA172387-04 Polysomy 21 in Acute Lymphoblastic Leukemia WEINSTOCK, DAVID DANA-FARBER CANCER INST MA $352,946
Childhood Leukemia 2016 NHLBI 1R01HL130034-01 The Cebpa Enhancer in Normal Hematopoiesis and Progression to AML FRIEDMAN, ALAN JOHNS HOPKINS UNIVERSITY MD $405,000
Childhood Leukemia 2016 NHLBI 5R01HL117737-17 Microchimerism as AlloImmunity NELSON, J. FRED HUTCHINSON CANCER RESEARCH CENTER WA $477,844
Childhood Leukemia 2016 NHLBI 1R01HL131444-01 The role of EVI1-induced hypermethylation in leukemogenesis. QIAN, ZHIJIAN UNIVERSITY OF ILLINOIS AT CHICAGO IL $399,708
Childhood Leukemia 2016 NCI 1R01CA201184-01 Biologic and Therapeutic Significance of miR-155 in AML MARCUCCI, GUIDO BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $574,050
Childhood Leukemia 2016 NCI 5R01CA190843-02 A Label-Free, Point-of-Care Platform to Diagnose Acute Promyelocytic Leukemia SOHN, LYDIA UNIVERSITY OF CALIFORNIA BERKELEY CA $311,458
Childhood Leukemia 2016 NCI 4R01CA164024-04 Identifying Cell Stress Proteins that Predict Clinical Response in Pediatric AML HORTON, TERZAH BAYLOR COLLEGE OF MEDICINE TX $309,159
Childhood Leukemia 2016 NCI 5R01CA192924-02 CSF2 receptor mediated actions in t(8;21) leukemia ZHANG, DONG-ER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $344,868
Childhood Leukemia 2016 NCI 5R21CA183623-02 Pediatric Cancer Salvia Biorepository GRAHAM, DAVID JOHNS HOPKINS UNIVERSITY MD $251,676
Childhood Leukemia 2016 NCI 5R01CA194057-02 Metabolic pathways in leukemia SCHUETZ, JOHN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $409,749
Childhood Leukemia 2016 NCI 5F30CA186466-02 Role of GSK3beta Subcellular Localization in AML Stemness IGNATZ-HOOVER, JAMES CASE WESTERN RESERVE UNIVERSITY OH $28,572
Childhood Leukemia 2016 NCI 5R01CA193235-02 Metabolic Regulation in Leukemia-Initatiating Cells NAKADA, DAISUKE BAYLOR COLLEGE OF MEDICINE TX $462,191
Childhood Leukemia 2016 NIGMS 4R01GM103999-04 Mouse Models of Functional Insertion Polymorphisms BURNS, KATHLEEN JOHNS HOPKINS UNIVERSITY MD $307,800
Childhood Leukemia 2016 NCI 5R01CA174683-03 Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia BHATIA, SMITA UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $620,968
Childhood Leukemia 2016 NCI 1R21CA194829-01A1 Metabolic regulation of T-ALL cellular proliferation and lifespan RATHMELL, JEFFREY VANDERBILT UNIVERSITY TN $18,375
Childhood Leukemia 2016 NCI 5R01CA185687-02 Risk of Pediatric and Adolescent Cancer Associated with Medical Imaging SMITH-BINDMAN, REBECCA UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $2,196,358
Childhood Leukemia 2016 NCI 4R01CA160872-05 Discovery and Optimization of AML Prognostic Biomarkers STIREWALT, DEREK FRED HUTCHINSON CANCER RESEARCH CENTER WA $458,821
Childhood Leukemia 2016 NCI 4R01CA172040-04 Microenvironment-Leukemia Communication Through Lectins HEISTERKAMP, NORA CHILDREN'S HOSPITAL OF LOS ANGELES CA $336,150
Childhood Leukemia 2016 NCI 5R01CA188520-02 Genome maintenance by Hdacs1,2 and their inhibition for Pre-B leukemia therapy BHASKARA, SRIVIDYA UNIVERSITY OF UTAH UT $340,838
Childhood Leukemia 2016 NCI 1R01CA195732-01A1 The Role of MMSET in the Pathogenesis and Progression of Lymphoid Malignancy LICHT, JONATHAN UNIVERSITY OF FLORIDA FL $343,125
Childhood Leukemia 2016 NCI 5P30CA021765-37 6702 Hematalogical Malignancies GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $693,252
Childhood Leukemia 2016 NCI 5P30CA021765-37 6709 Early Phase Clinical Research Support GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $255,476
Childhood Leukemia 2016 NCI 5P30CA021765-37 6716 Transdisciplinary Collaboration and Coordination GILBERTSON, RICHARD ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $318,644
Childhood Leukemia 2016 NCI 5R01CA169784-03 Genetic Dissection of Acute Myeloid Leukemia. AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $355,993
Childhood Leukemia 2016 NCI 5R01CA166429-05 Role of a Novel Homeobox Transcription Factor (HLX) in Acute Myeloid Leukemia STEIDL, ULRICH ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $384,342
Childhood Leukemia 2016 NCI 4R01CA174793-04 BET bromodomain inhibition as targeted therapy in acute myeloid leukemia VAKOC, CHRISTOPHER COLD SPRING HARBOR LABORATORY NY $557,762
Childhood Leukemia 2016 NCI 2R01CA142665-06 Glucocorticoids in Lymphoblastic Leukemia RELLING, MARY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $485,955
Childhood Leukemia 2016 NCI 2R01CA142874-06A1 Targeting PML for Leukemia Therapy PANDOLFI, PIER PAOLO BETH ISRAEL DEACONESS MEDICAL CENTER MA $465,791
Childhood Leukemia 2016 NCI 1R01CA194058-01A1 Painted erythrocyte carriers for therapy of acute myeloid leukemia SIMBERG, DIMITRI UNIVERSITY OF COLORADO DENVER CO $352,151
Childhood Leukemia 2016 NICHD 5R21HD081319-02 Combination strategies to enhance therapy for Ph-like B-ALL FRUMAN, DAVID UNIVERSITY OF CALIFORNIA-IRVINE CA $201,951
Childhood Leukemia 2016 NCI 4R01CA166770-05 Characterization of a T cell dysfunctional state induced in mice with AML KLINE, JUSTIN UNIVERSITY OF CHICAGO IL $327,850
Childhood Leukemia 2016 OD 4K01OD010554-06 Loss of EBF1 Expression: A Novel Murine Model for Human B-ALL RAMIREZ, JULITA UNIVERSITY OF WASHINGTON WA $78,062
Childhood Leukemia 2016 NCI 5R01CA178454-04 The role and functional mechanism of TET1 in MLL-rearranged leukemia CHEN, JIANJUN UNIVERSITY OF CINCINNATI OH $327,850
Childhood Leukemia 2016 NCI 5U10CA180886-03 COG NCTN Network Group Operations Center ADAMSON, PETER CHILDREN'S HOSP OF PHILADELPHIA PA $21,084,883
Childhood Leukemia 2016 NCI 5R01CA195642-02 Triad1 regulates myelopoiesis and functions as a leukemia suppressor EKLUND, ELIZABETH NORTHWESTERN UNIVERSITY AT CHICAGO IL $353,419
Childhood Leukemia 2016 NHLBI 5K08HL127269-02 Bone Marrow Microenvironmental Expression of Cytochrome P450 Enzymes GHIAUR, GABRIEL JOHNS HOPKINS UNIVERSITY MD $171,720
Childhood Leukemia 2016 NCI 4R01CA163452-04 Novel lysine deacetylase 6 Hsp domain inhibitors against AML CHOU, CHUNG-JEN JAMES MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $310,213
Childhood Leukemia 2016 NCI 5R01CA193842-02 Characterizing MSI2 in leukemia KHARAS, MICHAEL SLOAN-KETTERING INST CAN RESEARCH NY $414,827
Childhood Leukemia 2016 NCI 4P01CA101937-13 7522 Genomics of AML Clonality LEY, TIMOTHY WASHINGTON UNIVERSITY MO $331,298
Childhood Leukemia 2016 NCI 4P01CA101937-13 7523 Genomics of AML Relapse DIPERSIO, JOHN WASHINGTON UNIVERSITY MO $333,043
Childhood Leukemia 2016 NCI 4P01CA101937-13 7524 Genomics of Familial MDS/AML GRAUBERT, TIMOTHY WASHINGTON UNIVERSITY MO $338,993
Childhood Leukemia 2016 NCI 4P01CA101937-13 7525 Genomics of Teatment-Related AML LINK, DANIEL WASHINGTON UNIVERSITY MO $336,859
Childhood Leukemia 2016 NCI 4P01CA101937-13 7526 Clinical Database WESTERVELT, PETER WASHINGTON UNIVERSITY MO $268,229
Childhood Leukemia 2016 NCI 4P01CA101937-13 7527 Specimen Acquisition, Genomic, Transcriptomic and Epigenetic Profilling PAYTON, JACQUELINE WASHINGTON UNIVERSITY MO $227,227
Childhood Leukemia 2016 NCI 4P01CA101937-13 7528 Sequencing and Integrated Analysis of AML Genomes WILSON, RICHARD WASHINGTON UNIVERSITY MO $902,342
Childhood Leukemia 2016 NCI 4P01CA101937-13 7529 Administration LEY, TIMOTHY WASHINGTON UNIVERSITY MO $150,298
Childhood Leukemia 2016 NCI 5UM1CA183730-03 Collaborative Human Tissue Network (CHTN) RAMIREZ, NILSA RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $774,914
Childhood Leukemia 2016 NCI 5F30CA183497-03 Modeling Transformation: Myeloproliferative Neoplasms to Acute Myeloid Leukemia MCKENNEY, ANNA WEILL MEDICAL COLL OF CORNELL UNIV NY $48,576
Childhood Leukemia 2016 NCI 5U01CA183030-03 Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML LIU, YANG CHILDREN'S RESEARCH INSTITUTE DC $472,123
Childhood Leukemia 2016 NCI 5R01CA133379-08 The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia. AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $381,375
Childhood Leukemia 2016 NCI 5R01CA090576-16 Studies of BCR-ABL leukemogenesis in mice VAN ETTEN, RICHARD UNIVERSITY OF CALIFORNIA-IRVINE CA $274,559
Childhood Leukemia 2016 NCI 5R03CA195618-02 Biomarkers in pediatric versus adult myelodysplastic syndromes VERNERIS, MICHAEL UNIVERSITY OF MINNESOTA MN $76,000
Childhood Leukemia 2016 NCI 5R01CA175353-03 Deep sequencing for minimal residual disease detection in Acute Lymphoblastic Leu ROBINS, HARLAN FRED HUTCHINSON CANCER RESEARCH CENTER WA $648,389
Childhood Leukemia 2016 NCI 4R01CA177307-04 Targeting the MLL-WDR5 protein-protein interaction WANG, SHAOMENG UNIVERSITY OF MICHIGAN MI $451,476
Childhood Leukemia 2016 NCI 5F31CA196045-02 The role of PRDM16 in Leukemia CORRIGAN, DAVID COLUMBIA UNIVERSITY HEALTH SCIENCES NY $40,602
Childhood Leukemia 2016 NCI 4R01CA175215-04 Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer RADICH, JERALD FRED HUTCHINSON CANCER RESEARCH CENTER WA $585,953
Childhood Leukemia 2016 NCI 4R01CA166616-05 Mechanisms of resistance to clinically-effective FLT3 kinase inhibitors in AML SHAH, NEIL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $320,588
Childhood Leukemia 2016 NCI 4R01CA176091-04 Crenolanib and ponatinib for the treatment of FLT3 mutant AML SHAH, NEIL UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $328,888
Childhood Leukemia 2016 NCI 4R01CA101774-14 Mechanisms of Leukemogenesis in Down Syndrome CRISPINO, JOHN NORTHWESTERN UNIVERSITY AT CHICAGO IL $303,965
Childhood Leukemia 2016 NCI 7R01CA194094-02 Discovery and Development of a Selective pan-FLT3-ITD Kinase Inhibitor Clinical Candidate for the Treatment of FLT3-ITD-Driven AML LI, HONG-YU UNIV OF ARKANSAS FOR MED SCIS AR $370,810
Childhood Leukemia 2016 NCI 4R01CA151535-05 Role of TET proteins in myeloid malignancies RAO, ANJANA LA JOLLA INST FOR ALLERGY & IMMUNOLGY CA $370,180
Childhood Leukemia 2016 NCI 1R43CA203172-01 A New Small Molecule Targeted Therapeutic for Acute Myeloid Leukemia MU, XUEYAN TEAMEDON INTERNATIONAL, LLC MD $278,000
Childhood Leukemia 2016 NCI 5R21CA195689-02 Stromal Interactions and Leukemic Risk in Myelodysplastic Syndromes NAORA, HONAMI UNIVERSITY OF TX MD ANDERSON CAN CTR TX $174,000
Childhood Leukemia 2016 NCI 1F32CA203049-01 Targeting PRL2 phosphatase in acute myeloid leukemia NABINGER, SARAH INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $61,137
Childhood Leukemia 2016 NCI 5U01CA176063-03 ARID5B and disparities of childhood leukemia YANG, JUN ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $365,074
Childhood Leukemia 2016 NCI 1F31CA203161-01 Targeting PARP and RAD52 to induce "dual synthetic lethality" in leukemia patients identified by gene expression and mutation profiling SULLIVAN, KATHERINE TEMPLE UNIV OF THE COMMONWEALTH PA $29,195
Childhood Leukemia 2016 NIDDK 1F30DK108532-01 microRNA-22 and the microRNA-22/TET2 Network as Regulators of the Cell Fate Decision in Hematopoietic Stem Cells and in the Development of Myelodysplastic Syndrome. WEISS, CARY ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $48,576
Childhood Leukemia 2016 NCI 1F30CA203292-01 Chromatin dysregulation generated by recurrent point mutation in histone methyltransferase, MMSET, drives progression of lymphoid malignancies SWAROOP, ALOK UNIVERSITY OF FLORIDA FL $37,411
Childhood Leukemia 2016 NCI 1R01CA197991-01A1 Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia PARDEE, TIMOTHY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $354,563
Childhood Leukemia 2016 NCI 5R01CA132946-09 Pharmacogenomics of Ara-C in AML LAMBA, JATINDER UNIVERSITY OF FLORIDA FL $310,509
Childhood Leukemia 2016 NCI 4R01CA158350-05 Targeting the aberrant kinome-epigenome in AML GARZON, RAMIRO OHIO STATE UNIVERSITY OH $308,958
Childhood Leukemia 2016 NCI 5R01CA178030-03 Regulation of transcription and tumor suppression by MTG family members HIEBERT, SCOTT VANDERBILT UNIVERSITY TN $364,000
Childhood Leukemia 2016 NCI 5F30CA196244-02 The role of the aryl hydrocarbon receptor in natural killer cell development in normal and acute myeloid leukemia donors SCOVILLE, STEVEN OHIO STATE UNIVERSITY OH $48,576
Childhood Leukemia 2016 NCI 5K08CA174750-03 Inhibiting STAT1 as a novel graft-versus-host/graft-versus-leukemia therapy CAPITINI, CHRISTIAN UNIVERSITY OF WISCONSIN-MADISON WI $178,740
Childhood Leukemia 2016 NCI 5R21CA194217-02 Targeting osteoblasts to inhibit AML HEDIN, KAREN MAYO CLINIC ROCHESTER MN $172,913
Childhood Leukemia 2016 NIAID 5R21AI119894-02 Analysis of the role of immune deficiency in E2A-/- T cell lymphomagenesis KEE, BARBARA UNIVERSITY OF CHICAGO IL $227,372
Childhood Leukemia 2016 NCI 5R01CA175761-03 Function of the PR domain of the MDSI-EVI1 in MLL fusion protein leukemogenesis PERKINS, ARCHIBALD UNIVERSITY OF ROCHESTER NY $356,888
Childhood Leukemia 2016 NHLBI 5R01HL114582-03 Role of TRAF6 in Myelodysplastic Syndromes STARCZYNOWSKI, DANIEL CINCINNATI CHILDRENS HOSP MED CTR OH $398,308
Childhood Leukemia 2016 NIEHS 4R01ES022054-05 Study DNA repair in preventing MDS and AML after radiation and benzene exposure HASTY, EDWARD UNIVERSITY OF TEXAS HLTH SCIENCE CENTER TX $334,415
Childhood Leukemia 2016 NCI 5R00CA168996-04 The role of Jmjd1c in normal and leukemic hematopoiesis ZHU, NAN BLOODCENTER OF WISCONSIN, INC. WI $243,927
Childhood Leukemia 2016 NCI 5R21CA194608-02 Cytoplasmic FOXM1 contributes to the higher complete remission and longer overall survival of AML patients after chemotherapy GARTEL, ANDREI UNIVERSITY OF ILLINOIS AT CHICAGO IL $173,873
Childhood Leukemia 2016 NCI 5R03CA188733-02 Genetic susceptibility to acute lymphocytic and myeloid leukemia HAHN, THERESA ROSWELL PARK CANCER INSTITUTE CORP NY $87,750
Childhood Leukemia 2016 NCI 5R01CA194552-02 RETARGETING AGENTS TO TREAT AML DIPERSIO, JOHN WASHINGTON UNIVERSITY MO $380,068
Childhood Leukemia 2016 NCI 5K08CA194256-02 Chimeric Antigen Receptor T cell Therapy for Acute Myeloid Leukemia (AML) GILL, SAAR UNIVERSITY OF PENNSYLVANIA PA $167,832
Childhood Leukemia 2016 NCI 4R01CA169162-05 Targeting non-classical oncogenes as therapy for T-ALL DIACOVO, THOMAS COLUMBIA UNIVERSITY HEALTH SCIENCES NY $332,000
Childhood Leukemia 2016 NCI 5R01CA173852-03 Role of p21 activated kinase in Leukemogenesis KAPUR, REUBEN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $323,700
Childhood Leukemia 2016 NCI 5R01CA193776-02 Improving risk allocation and developing novel therapies for children with T-ALL TEACHEY, DAVID CHILDREN'S HOSP OF PHILADELPHIA PA $626,176
Childhood Leukemia 2016 NCI 5R01CA194923-02 Long non-coding RNAs in hematopoiesis and blood malignancy AIFANTIS, IANNIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $457,533
Childhood Leukemia 2016 NCI 5R01CA098571-12 Molecular Mechanisms of eIF4E mediated transformation BORDEN, KATHERINE UNIVERSITY OF MONTREAL CANADA $227,057
Childhood Leukemia 2016 NCI 5R01CA185062-03 (PQB3) CD4 T cell response to BCR-ABL-positive Leukemia FARRAR, MICHAEL UNIVERSITY OF MINNESOTA MN $312,341
Childhood Leukemia 2016 NCI 4R01CA161202-05 Functional analysis of leukemic CREBBP mutations MULLIGHAN, CHARLES ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $363,125
Childhood Leukemia 2016 NCI 5R01CA190509-02 The function of cyclin C in tumorigenesis SICINSKI, PETER DANA-FARBER CANCER INST MA $453,569
Childhood Leukemia 2016 NCI 5R21CA181875-02 Cdk5 signaling in ICN1-induced T Cell Leukemogenesis HUANG, ALEX CASE WESTERN RESERVE UNIVERSITY OH $172,369
Childhood Leukemia 2016 NCI 4R01CA178765-04 Transcriptional regulatory mechanisms in B cell development and leukemogenesis ROEDER, ROBERT ROCKEFELLER UNIVERSITY NY $565,455
Childhood Leukemia 2016 NCI 4R01CA162665-05 Targeting Leukemia Stem Cells with Dietary Selenium PRABHU, KUMBLE PENNSYLVANIA STATE UNIVERSITY-UNIV PARK PA $303,222
Childhood Leukemia 2016 NCI 4R01CA171972-04 Targeted Elimination of Cancer Stem Cells for AML Therapy LIU, YANG CHILDREN'S RESEARCH INSTITUTE DC $463,347
Childhood Leukemia 2016 NCI 5R01CA185058-03 Impact of low IL-10 levels at birth and leukemia risk WIEMELS, JOSEPH UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $624,355
Childhood Leukemia 2016 NCI 4R01CA172385-04 Validation and Development of WEE1 as a therapeutic target in AML PORTER, CHRISTOPHER UNIVERSITY OF COLORADO DENVER CO $316,213
Childhood Leukemia 2016 NCI 5R01CA182284-04 Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats COLE, PETER ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $346,525
Childhood Leukemia 2016 NCI 5R01CA173877-04 Targeted Therapy for AML Stem Cells BHALLA, KAPIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $332,000
Childhood Leukemia 2016 NCI 5R01CA171338-04 Novel Targeted Therapy for AML BHALLA, KAPIL UNIVERSITY OF TX MD ANDERSON CAN CTR TX $332,000
Childhood Leukemia 2016 NCI 5R01CA064140-23 Role of AML1-ETO in Acute Leukemia HIEBERT, SCOTT VANDERBILT UNIVERSITY TN $353,250
Childhood Leukemia 2016 NIDDK 5R01DK100960-03 Hematopoiesis in Down Syndrome iPS cells: Correction by Chromosome 21 Silencing LAWRENCE, JEANNE UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $291,450
Childhood Leukemia 2016 NHLBI 5F30HL128011-02 HSC-Independent Progenitors Contribute to Juvenile Myelomonocytic Leukemia TARNAWSKY, STEFAN INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $27,801
Childhood Leukemia 2016 NCI 4R01CA173085-04 Mechanisms linking RAS signals to disordered hematopoiesis and myeloid neoplasia BRAUN, BENJAMIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $328,888
Childhood Leukemia 2016 NCI 5R01CA172408-03 Role of Asxl1 in normal hematopoiesis and pathogenesis of myeloid malignancies YANG, FENG-CHUN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $318,513
Childhood Leukemia 2016 NCI 4R01CA090321-14 Role of Sialic Acid Modification in ALL Survival and Drug Resistance HEISTERKAMP, NORA CHILDREN'S HOSPITAL OF LOS ANGELES CA $266,069
Childhood Leukemia 2016 NCI 5R01CA188269-03 Developing CRM1 inhibitors in AML GARZON, RAMIRO OHIO STATE UNIVERSITY OH $319,550
Childhood Leukemia 2016 NCI 4R01CA172896-04 Investigating the mechanism of ITGA4/6-mediated chemoprotection of ALL cells KIM, YONG-MI CHILDREN'S HOSPITAL OF LOS ANGELES CA $335,154
Childhood Leukemia 2016 NCI 4R01CA160747-05 DISCOVERY OF SMALL MOLECULAR ACTIVATORS OF NR4A ORPHAN NUCLEAR RECEPTORS CONNEELY, ORLA BAYLOR COLLEGE OF MEDICINE TX $324,738
Childhood Leukemia 2016 NCI 1R01CA204308-01 Modulating signaling pathways in endothelial cells to abate leukemic progression. BUTLER, JASON WEILL MEDICAL COLL OF CORNELL UNIV NY $383,445
Childhood Leukemia 2016 NCI 4R01CA164120-04 Cellular and molecular basis of microRNA-29a Induced Acute Myeloid Leukemia PARK, CHRISTOPHER SLOAN-KETTERING INST CAN RESEARCH NY $366,860
Childhood Leukemia 2016 NCI 5R25CA183725-02 Problem-Solving Skills Training for Clinicians Providing Psychosocial Care in Pediatric Oncology SAHLER, OLLE JANE UNIVERSITY OF ROCHESTER NY $309,623
Childhood Leukemia 2016 NCI 5R01CA057138-25 Employing the Myc Transcriptional Network to Reveal Oncogenic Pathways EISENMAN, ROBERT FRED HUTCHINSON CANCER RESEARCH CENTER WA $635,460
Childhood Leukemia 2016 NCI 1K08CA204734-01 Determining the Role of BCOR Mutations in Myeloid Malignancies LINDSLEY, ROBERT DANA-FARBER CANCER INST MA $176,970
Childhood Leukemia 2016 NCI 5R01CA195218-02 Innovative solutions to spatial uncertainty in geocoding COCKBURN, MYLES UNIVERSITY OF SOUTHERN CALIFORNIA CA $377,438
Childhood Leukemia 2016 NCI 4R01CA044722-26 Vitamin D Analogs as Adjuvants in Chemotherapy of Cancer STUDZINSKI, GEORGE RBHS-NEW JERSEY MEDICAL SCHOOL NJ $203,601
Childhood Leukemia 2016 NCI 4P01CA119070-10 7559 Notch Target Gene Regulation in Normal and Malignant T Cells PEAR, WARREN UNIVERSITY OF PENNSYLVANIA PA $295,553
Childhood Leukemia 2016 NCI 4P50CA171963-04 8326 Molecular Determinants of Decitabine Response LEY, TIMOTHY WASHINGTON UNIVERSITY MO $368,008
Childhood Leukemia 2016 NCI 4P50CA171963-04 8328 RNA Splicing Modulators for MDS/AML GRAUBERT, TIMOTHY WASHINGTON UNIVERSITY MO $401,522
Childhood Leukemia 2016 NCI 5R01CA175026-03 Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML REDELL, MICHELE BAYLOR COLLEGE OF MEDICINE TX $402,343
Childhood Leukemia 2016 NCI 4R01CA169398-05 Phenotype-Genotype Associations with Symptoms During Childhood Leukemia Treatment HOCKENBERRY, MARILYN DUKE UNIVERSITY NC $603,111
Childhood Leukemia 2016 NCI 4R01CA163926-04 Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia GREEN, MICHAEL UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $347,563
Childhood Leukemia 2016 NIGMS 5P50GM115279-02 7544 CPML - Core A: Administrative Core RELLING, MARY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $204,478
Childhood Leukemia 2016 NIGMS 5P50GM115279-02 7545 CPML - Core B: Cell & Molecular Core CREWS, KRISTINE ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $348,034
Childhood Leukemia 2016 NIGMS 5P50GM115279-02 7546 CPML - Core C: Bioinformatics & Biostatistical Core ZHANG, JINGHUI ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $596,871
Childhood Leukemia 2016 NIGMS 5P50GM115279-02 7547 CPML - Project 1: Genome-wide Studies of ALL Response MULLIGHAN, CHARLES ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $737,381
Childhood Leukemia 2016 NIGMS 5P50GM115279-02 7548 CPML - Project 2: Genome-wide Studies of ALL Drug Sensitivity EVANS, WILLIAM ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $698,840
Childhood Leukemia 2016 NIGMS 5P50GM115279-02 7549 CPML - Project 3: Genome-wide Studies of Adverse Effects RELLING, MARY ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $384,140
Childhood Leukemia 2016 NCI 4R01CA178979-04 CHEK1 and WEE1 Inhibition as Therapeutic Strategies in AML TIBES, RAOUL MAYO CLINIC ARIZONA AZ $344,450
Childhood Leukemia 2016 NCI 5K08CA190815-02 REGULATORY MECHANISMS OF HOX GENE EXPRESSION IN ACUTE MYELOID LEUKEMIA SPENCER, DAVID WASHINGTON UNIVERSITY MO $166,298
Childhood Leukemia 2016 NCI 4R01CA114563-10 Biology and Prognostic Implications of FLT3 Mutations in AML MESHINCHI, SOHEIL FRED HUTCHINSON CANCER RESEARCH CENTER WA $429,543
Childhood Leukemia 2016 NCI 5R01CA189074-02 Small molecule CXCR4 modulators as molecular probes for studying AML SCHILTZ, GARY NORTHWESTERN UNIVERSITY IL $539,886
Childhood Leukemia 2016 NCI 1R21CA205644-01 (PQ11) Reversing exosome-mediated immune suppression - a novel strategy for cancer therapy WHITESIDE, THERESA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $167,475
Childhood Leukemia 2016 NCI 4K08CA166229-04 HISTONE H3 METHYLATION AND EPIGENOMICS IN ACUTE LEUKEMIA WARTMAN, LUKAS WASHINGTON UNIVERSITY MO $153,699
Childhood Leukemia 2016 NCI 1R21CA205828-01 Examining the role of normal hematopoiesis in supporting incipient myelodysplasia PERKINS, ARCHIBALD UNIVERSITY OF ROCHESTER NY $200,807
Childhood Leukemia 2016 NCI 1R21CA197441-01A1 Unraveling the Function of RNA-Binding proteins in B-lympoblastic Leukemia RAO, DINESH UNIVERSITY OF CALIFORNIA LOS ANGELES CA $167,475
Childhood Leukemia 2016 NCI 1R21CA205912-01 Mediator Kinases and AML Cell Proliferation TAATJES, DYLAN UNIVERSITY OF COLORADO CO $208,967
Childhood Leukemia 2016 NCI 1R21CA205936-01 SIRT5 as a Therapeutic Target in Acute Myeloid Leukemia DEININGER, MICHAEL UNIVERSITY OF UTAH UT $196,402
Childhood Leukemia 2016 NCI 5F30CA196123-02 Mutations in Runx1 and epigenetic modifiers cooperate in leukemogenesis BELLISSIMO, DANA UNIVERSITY OF PENNSYLVANIA PA $47,711
Childhood Leukemia 2016 NCI 4K12CA090433-15 Pediatric Oncology Clinical Research Training Program POPLACK, DAVID BAYLOR COLLEGE OF MEDICINE TX $805,190
Childhood Leukemia 2016 NCI 5P30CA013696-42 6105 Lymphoid Development and Malignancy Program EMERSON, STEPHEN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $35,133
Childhood Leukemia 2016 NCI 5P30CA013696-42 6127 Recruitment EMERSON, STEPHEN COLUMBIA UNIVERSITY HEALTH SCIENCES NY $95,447
Childhood Leukemia 2016 NCI 5R01CA104509-12 Molecular Mechanism of Leukemogenesis Involving AML1-ETO ZHANG, DONG-ER UNIVERSITY OF CALIFORNIA SAN DIEGO CA $331,313
Childhood Leukemia 2016 NCI 5R01CA187318-02 Molecular understanding of cytokine-Ras signals in leukemic bone marrow ROOSE, JEROEN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $353,777
Childhood Leukemia 2016 NCI 4K08CA169809-05 Metabolic contribution to cell viability and therapy resistance in the acute PARDEE, TIMOTHY WAKE FOREST UNIVERSITY HEALTH SCIENCES NC $167,980
Childhood Leukemia 2016 NCI 5R21CA186912-02 Targeting PKM2-InsP3R interaction to treat AML DISTELHORST, CLARK CASE WESTERN RESERVE UNIVERSITY OH $222,296
Childhood Leukemia 2016 NCI 2R01CA096899-11 Mechanism(s) of TAL1-and NOTCH1-mediated Leukemogenesis KELLIHER, MICHELLE UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $358,031
Childhood Leukemia 2016 NCI 2R01CA151898-06A1 CRLF2 signaling in B-cell acute lymphoblastic leukemia WEINSTOCK, DAVID DANA-FARBER CANCER INST MA $392,969
Childhood Leukemia 2016 NCI 1R01CA190661-01A1 Novel Biomarkers to Risk-Stratify AML Patients with NPM1^Pos/FLT3-IT^Neg Genotype STIREWALT, DEREK FRED HUTCHINSON CANCER RESEARCH CENTER WA $576,165
Childhood Leukemia 2016 NCI 4P01CA018029-41 5857 Molecular Diagnostics RADICH, JERALD FRED HUTCHINSON CANCER RESEARCH CENTER WA $135,000
Childhood Leukemia 2016 NCI 5K08CA191091-02 Epigenetic mechanisms of drug resistance in T-cell acute lymphoblastic leukemia KNOECHEL, BIRGIT DANA-FARBER CANCER INST MA $177,120
Childhood Leukemia 2016 NCI 1R01CA201496-01A1 Novel RNA-Directed Therapy for the Treatment of Acute Myeloid Leukemia ROSEN, STEVEN BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $499,409
Childhood Leukemia 2016 NCI 5R21CA198358-02 Novel therapeutics of targeting mTOR pathway in T-cell leukemia GUO, FUKUN CINCINNATI CHILDRENS HOSP MED CTR OH $203,580
Childhood Leukemia 2016 NCI 5R21CA188881-02 Phosphoproteomic signatures for early detection and stratification of AML MARTO, JARROD DANA-FARBER CANCER INST MA $190,852
Childhood Leukemia 2016 NCI 1K08CA184419-01A1 Chemotherapy resistance induced by SETD2 loss in leukemia MAR, BRENTON DANA-FARBER CANCER INST MA $177,120
Childhood Leukemia 2016 NCI 1K08CA181507-01A1 Analysis of TET2 function in acute leukemia SHIH, ALAN SLOAN-KETTERING INST CAN RESEARCH NY $180,036
Childhood Leukemia 2016 NCI 4K08CA169485-04 Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W CHAPUIS, AUDE FRED HUTCHINSON CANCER RESEARCH CENTER WA $171,372
Childhood Leukemia 2016 NCI 5F30CA189553-03 Role of MLL1 and MLL1 leukemogenic fusions in maintaining transcriptional memory HSU, SARAH UNIVERSITY OF PENNSYLVANIA PA $30,341
Childhood Leukemia 2016 NCI 5F32CA180615-03 Molecular Mechanism of Osteoblastic Inhibition in Myeloid Malignancies FRISCH, BENJAMIN UNIVERSITY OF ROCHESTER NY $59,970
Childhood Leukemia 2016 NCI 5K99CA197869-02 Functional dissection of oncogenic enhancers HERRANZ BENITO, DANIEL COLUMBIA UNIVERSITY HEALTH SCIENCES NY $170,856
Childhood Leukemia 2016 NCI 5F31CA183342-02 The Role of Shp2 Phosphatase Activity in FLT3-ITD+ Acute Myeloid Leukemia RICHINE, BRIANA INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $37,324
Childhood Leukemia 2016 NCI 4R01CA180037-04 (PQD1) Response and Resistance to Inhibitors of Ras Effectors in Blood Cancers SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $328,888
Childhood Leukemia 2016 NCI 5R21CA191458-02 Targeting alternative transcription/translation of RUNX1-ETO fusion gene ZHANG, JIWANG LOYOLA UNIVERSITY CHICAGO IL $164,213
Childhood Leukemia 2016 NCI 5K08CA184418-03 PI3K Pathway Inhibition for Philadelphia-Like Acute Lymphoblastic Leukemia TASIAN, SARAH CHILDREN'S HOSP OF PHILADELPHIA PA $169,657
Childhood Leukemia 2016 NCI 5R01CA198089-02 Understanding and Targeting Chemotherapy Resistance in Acute Myeloid Leukemia CARROLL, MARTIN UNIVERSITY OF PENNSYLVANIA PA $663,135
Childhood Leukemia 2016 NCI 5R21CA198621-02 How Does FLT3 Mutation Regulate Myeloid Differentiation in Acute Myeloid Leukemia CARROLL, MARTIN UNIVERSITY OF PENNSYLVANIA PA $208,880
Childhood Leukemia 2016 NCI 5R01CA181024-03 Prevention of bone loss after pediatric hematopoietic cell transplantation PETRYK, ANNA UNIVERSITY OF MINNESOTA MN $477,236
Childhood Leukemia 2016 NIGMS 1F31GM116569-01A1 Developing an Artemis Nuclease Inhibitor to Potentially Treat Acute Lymphoblastic Leukemia ESGUERRA, ZITADEL ANNE UNIVERSITY OF SOUTHERN CALIFORNIA CA $42,218
Childhood Leukemia 2016 NCI 5R01CA036401-33 Pharmacogenomics of Childhood Leukemia ALL EVANS, WILLIAM ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $726,561
Childhood Leukemia 2016 NCI 5F31CA192822-02 Differential Regulation of PI3KC2beta by Ras Protooncogenes In Acute Myeloid Leukemia SMITH, RUSSELL UNIVERSITY OF ILLINOIS AT CHICAGO IL $43,576
Childhood Leukemia 2016 NCI 5R21CA188968-02 Translocations And Their Widespread Impact on Gene Regulation SKOK, JANE NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $183,950
Childhood Leukemia 2016 NCI 5R01CA193651-02 Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL GUTIERREZ, ALEJANDRO CHILDREN'S HOSPITAL CORPORATION MA $451,095
Childhood Leukemia 2016 NCI 5R01CA196604-02 Direct coregulation of Notch1 by Zmiz1 in T-cell leukemia CHIANG, MARK UNIVERSITY OF MICHIGAN MI $354,563
Childhood Leukemia 2016 NCI 5R01CA102031-11 Pharmacological modulation of epigenetic changes in AML MARCUCCI, GUIDO BECKMAN RESEARCH INSTITUTE/CITY OF HOPE CA $342,107
Childhood Leukemia 2016 NCI 7R01CA176745-06 Targeting to Epigenetic Modications in ALL ARMSTRONG, SCOTT DANA-FARBER CANCER INST MA $402,250
Childhood Leukemia 2016 NCI 5R01CA187397-03 Exercise and QUality diet After Leukemia TONOREZOS, EMILY SLOAN-KETTERING INST CAN RESEARCH NY $675,314
Childhood Leukemia 2016 NCI 1R01CA206210-01 Therapeutic targeting of glutamine metabolism in MDS KONOPLEVA, MARINA UNIVERSITY OF TX MD ANDERSON CAN CTR TX $506,879
Childhood Leukemia 2016 NCI 4R01CA166835-05 Targeting p300 and lysine acetylation in AML NIMER, STEPHEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $317,475
Childhood Leukemia 2016 NCI 4UM1CA097452-15 Pediatric Phase 1/Pilot Consortium WEIGEL, BRENDA CHILDREN'S HOSP OF PHILADELPHIA PA $3,181,202
Childhood Leukemia 2016 NCI 5U01CA199000-02 Pediatric Preclinical Testing Consortium - Leukemia LOCK, RICHARD UNIVERSITY OF NEW SOUTH WALES AUSTRA $385,674
Childhood Leukemia 2016 NCI 5P30CA125123-10 8015 Pediatric Cancer Program (Project-007) POPLACK, DAVID BAYLOR COLLEGE OF MEDICINE TX $43,684
Childhood Leukemia 2016 NIAMS 4R01AR054447-09 The Osteoblast as a Determinant of Leukemogenesis KOUSTENI, STAVROULA COLUMBIA UNIVERSITY HEALTH SCIENCES NY $341,711
Childhood Leukemia 2016 NCI 5R35CA197697-02 Mechanisms of regulation by RNA in acute myeloid leukemia TENEN, DANIEL BETH ISRAEL DEACONESS MEDICAL CENTER MA $1,042,185
Childhood Leukemia 2016 NCI 5R01CA187903-02 CHARACTERIZATION OF THE MOLECULAR INTERPLAY BETWEEN HOXA9 AND OGT IN ACUTE LEUKEMIA RUAL, JEAN-FRANCOIS UNIVERSITY OF MICHIGAN MI $354,563
Childhood Leukemia 2016 NIAID 4R01AI038339-20 Transcriptional Regulation of Innate-Like T Cells BENDELAC, ALBERT UNIVERSITY OF CHICAGO IL $447,050
Childhood Leukemia 2016 NHLBI 1F31HL132420-01 Aberrant Ubiquitin-Editing in the Pathogenesis of Myeloid Malignancies SMITH, MOLLY CINCINNATI CHILDRENS HOSP MED CTR OH $36,557
Childhood Leukemia 2016 NCI 5K08CA188529-03 Genomic profiling and development of murine models of transformation of MPNs RAMPAL, RAAJIT SLOAN-KETTERING INST CAN RESEARCH NY $178,200
Childhood Leukemia 2016 NCI 1F31CA206338-01 Myc transcriptional regulation in T-ALL FORSYTH, KATHERINE UNIVERSITY OF PENNSYLVANIA PA $43,576
Childhood Leukemia 2016 NCI 4P50CA100632-14 SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia KANTARJIAN, HAGOP UNIVERSITY OF TX MD ANDERSON CAN CTR TX $2,161,999
Childhood Leukemia 2016 NCI 5K08CA187577-03 Investigating Resistance to FLT3 Inhibitors in AML SMITH, CATHERINE UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $175,808
Childhood Leukemia 2016 NCI 1R13CA206376-01 New Frontiers in Pediatric Stem Cell Transplantation JACOBSOHN, DAVID CHILDREN'S RESEARCH INSTITUTE DC $5,000
Childhood Leukemia 2016 NHLBI 1R13CA206376-01 New Frontiers in Pediatric Stem Cell Transplantation JACOBSOHN, DAVID CHILDREN'S RESEARCH INSTITUTE DC $7,500
Childhood Leukemia 2016 NCI 5R35CA197561-02 Molecular Pathogenesis of Acute Myeloid Leukemia LEY, TIMOTHY WASHINGTON UNIVERSITY MO $915,000
Childhood Leukemia 2016 NCI 5F31CA189452-03 Tumor Suppressor RASSF2 in t(8;21) Acute Myeloid Leukemia STONER, SAMUEL UNIVERSITY OF CALIFORNIA SAN DIEGO CA $35,243
Childhood Leukemia 2016 NCI 4P30CA082103-18 6393 Pediatric Malignancies MCCORMICK, FRANK UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $163
Childhood Leukemia 2016 NCI 5R01CA175737-03 Perinatal immune development and risk of childhood acute lymphoblastic leukemia WIEMELS, JOSEPH UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $618,506
Childhood Leukemia 2016 NCI 4K08CA154975-05 The role of Hedgehog/Gli in normal hematopoiesis and leukemia MERCHANT, AKIL UNIVERSITY OF SOUTHERN CALIFORNIA CA $175,824
Childhood Leukemia 2016 NCI 4K08CA169055-05 Genetic and epigenetic basis of relapse in acute myeloid leukemia GARRETT-BAKELMAN, FRANCINE WEILL MEDICAL COLL OF CORNELL UNIV NY $148,320
Childhood Leukemia 2016 NCI 5R01CA136551-08 Targeted therapy of B cell malignances with CAR-T cells of defined composition RIDDELL, STANLEY FRED HUTCHINSON CANCER RESEARCH CENTER WA $560,424
Childhood Leukemia 2016 NCI 5P01CA078902-18 5394 Project 2: Stem Cell Allografts for Acute Leukemia and Myelodysplasia SANDMAIER, BRENDA FRED HUTCHINSON CANCER RESEARCH CENTER WA $239,833
Childhood Leukemia 2016 NIEHS 5P50ES018172-07 5328 Core A - Administrative Core METAYER, CATHERINE UNIVERSITY OF CALIFORNIA BERKELEY CA $187,961
Childhood Leukemia 2016 NIEHS 5P50ES018172-07 5329 Project 1 - In Utero Chemical Exposures, Immune Status, and Childhood Leukemia METAYER, CATHERINE UNIVERSITY OF CALIFORNIA BERKELEY CA $181,287
Childhood Leukemia 2016 NIEHS 5P50ES018172-07 5330 Project 2 - Identifying In Utero Exposures that are Risk Factors for Childhood Leukemia RAPPAPORT, STEPHEN UNIVERSITY OF CALIFORNIA BERKELEY CA $171,522
Childhood Leukemia 2016 NIEHS 5P50ES018172-07 5331 Project 3 - Prenatal Exposures, Constitutive Genetics, DNA Methylation & Childhood Leukemia WIEMELS, JOSEPH UNIVERSITY OF CALIFORNIA BERKELEY CA $156,321
Childhood Leukemia 2016 NIEHS 5P50ES018172-07 5332 Core B - Community Outreach and Translation Core MILLER, MARK UNIVERSITY OF CALIFORNIA BERKELEY CA $90,999
Childhood Leukemia 2016 NIEHS 5P50ES018172-07 5333 Core C - Mouse Model Service Core KOGAN, SCOTT UNIVERSITY OF CALIFORNIA BERKELEY CA $62,910
Childhood Leukemia 2016 NCI 5P01CA066996-18 7123 Mitochondrial determination of response to targeted AML therapies LETAI, ANTHONY DANA-FARBER CANCER INST MA $368,774
Childhood Leukemia 2016 NCI 5P01CA066996-18 7124 Determination of the mechanism of lenalidomide activity in acute myeloid leukemia EBERT, BENJAMIN BRIGHAM AND WOMEN'S HOSPITAL MA $327,877
Childhood Leukemia 2016 NCI 5P01CA066996-18 7126 Novel Epigenetic Approaches in AML BRADNER, JAMES DANA-FARBER CANCER INST MA $471,092
Childhood Leukemia 2016 NCI 5R01CA180519-03 Novel anthraquinones induce apoptosis by disruption MDM2/MDM4 interactions WANG, BINGHE GEORGIA STATE UNIVERSITY GA $442,311
Childhood Leukemia 2016 NHLBI 7R01HL128173-02 Multiscale Modeling of Myelodysplastic Syndromes COREY, SETH VIRGINIA COMMONWEALTH UNIVERSITY VA $749,005
Childhood Leukemia 2016 NCI 5R21CA187226-02 Markers of Cognitive Decline During Treatment for Childhood ALL COLE, PETER ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $215,938
Childhood Leukemia 2016 NCI 5P01CA171983-04 7611 Targeting Ceramide Metabolism in AML KESTER, MARK PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $300,315
Childhood Leukemia 2016 NCI 5P01CA171983-04 7612 Targeting Acid Ceramidase in AML LOUGHRAN, THOMAS PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $319,896
Childhood Leukemia 2016 NCI 5P01CA171983-04 7613 Targeting Sphingosine Kinase in AML WANG, HONG-GANG PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $224,096
Childhood Leukemia 2016 NCI 5P01CA171983-04 7616 Targeted Sphing''omics'' Core FOX, TODD PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $136,170
Childhood Leukemia 2016 NCI 5P01CA171983-04 7411 Animal Modeling and Clinical Resources Core CLAXTON, DAVID PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $340,284
Childhood Leukemia 2016 NCI 5R01CA138744-07 Tyrosine kinase inhibitors for the treatment of childhood AML BAKER, SHARYN OHIO STATE UNIVERSITY OH $343,388
Childhood Leukemia 2016 RMAP 5K01ES026842-02 Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia PAGUIRIGAN, AMY FRED HUTCHINSON CANCER RESEARCH CENTER WA $119,535
Childhood Leukemia 2016 NCI 5K01CA188151-02 Targeted Alpha Radioimmunotherapy with Haploidentical Bone Marrow Transplantation for AML OROZCO, JOHNNIE FRED HUTCHINSON CANCER RESEARCH CENTER WA $169,020
Childhood Leukemia 2016 NCI 5U54CA196519-02 7041 Project 3: Efficacy of MEK Inhibition in Juvenile Myelomonocytic Leukemia SHANNON, KEVIN UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $408,012
Childhood Leukemia 2016 NIGMS 2P20GM103548-06 5159 Exploring the origins of childhood leukemia: investigating transcriptional networks in hematopoiesis and acute leukemia MILANOVICH, SAMUEL SANFORD RESEARCH/USD SD $299,267
Childhood Leukemia 2016 NCI 5R00CA188293-03 Exploring a new therapeutic approach through targeting epigenetic enzymes in ALL NTZIACHRISTOS, PANAGIOTIS NORTHWESTERN UNIVERSITY AT CHICAGO IL $249,000
Childhood Leukemia 2016 NCI 4R00CA181500-03 The Role of Protein Tyrosine Phosphate PRL3 in Leukemia Development BLACKBURN, JESSICA UNIVERSITY OF KENTUCKY KY $249,000
12


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer